Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2007, p. 605-621, Vol. 27, No. 2
0270-7306/07/$08.00+0 doi:10.1128/MCB.00699-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel
Received 23 April 2006/ Returned for modification 30 June 2006/ Accepted 1 November 2006
|
|
|---|
cells. Yif1 delivery to the vacuole was observed in other late endosome-Golgi trafficking mutants, including ypt6
, snx4
, and vps26
cells. Thus, Btn2 facilitates specific protein retrieval from a late endosome to the Golgi apparatus, a process which may be adversely affected in patients with Batten disease. |
|
|---|
The yeast Saccharomyces cerevisiae Btn2 protein has similarity to Hook1, a coiled-coil protein that associates with the cytoskeleton in mammalian cells (86) and with endocytic vesicles in Drosophila melanogaster (45). Hook1 in Drosophila is involved in the endocytosis of membrane receptors and their delivery to multivesicular bodies (MVBs) (45, 79). As MVBs represent a step in the maturation of late endosomes which fuse with lysosomes in higher organisms and vacuoles in yeast (32, 42, 63), it suggests a role for Hook proteins in lysosome/vacuole biogenesis. Interestingly, both the Drosophila and the mammalian Hook proteins interact with orthologs of the HOPS/class C vacuolar protein sorting complex (encoded by the vps gene) (composed of Vps11, Vps16, Vps18, and Vps33) (56, 69). This complex tethers membranes to both endosomes and vacuoles in yeast (61) and to early and late endosomes in mammals (64, 69). Thus, the HOPS complex mediates transport from either the Golgi apparatus or the endosomes to the lysosome/vacuole. The yeast HOPS complex was shown to interact with SNAREs involved in vacuolar fusion (i.e., Vam3, Nyv1, and Vti1) (61, 65, 72) and to fractionate with Pep12, a t-SNARE from late endosomes (4). Components of the mammalian HOPS complex interact with SNAREs involved in endosome fusion events (i.e., Syn6, Syn7, Syn13, and VAMP8) (69). Correspondingly, mammalian Hook1 was found in complexes containing these SNAREs, suggesting a possible role for the protein in membrane tethering and/or fusion at the endosomal level (56, 69).
Here we
identify Btn2 as a SNARE- and retromer-binding protein that facilitates
late endosome-Golgi protein sorting in yeast. By employing the
two-hybrid assay, we found that Btn2 interacts with theSnc1 and Snc2 (Snc1/2) v-SNARE proteins, which mediate both exocytosis
and endocytosis (34,
66). This suggested that
Btn2 might have either SNARE regulatory or trafficking functions, like
Vsm1 or Gcs1, which we identified earlier as Snc-binding proteins
(49,
70). As the function of
Btn2 is unclear, we examined the role of Btn2 in intracellular protein
trafficking. First, we found that Btn2 binds to the assembled endocytic
SNARE complex (e.g., Snc1/2, Tlg1, Tlg2, and Vti1), which facilitates
protein recycling to endosomes and the trans Golgi apparatus
(10). Second, we found
that Btn2-red fluorescent protein (RFP) and Btn2-green fluorescent
protein (GFP) colocalize with a variety of endosomal markers, including
Snx4 (38), Tlg2
(2,
40), and Vps27. Vps27 is
found on late endosomes and MVBs and is involved in the delivery of
membrane proteins to the vacuole
(62,
63). Third, the deletion
of BTN2 results in the mislocalization of a Golgi marker, Yif1
(51), to the vacuole, as
first shown earlier by others
(14). We observed Yif1
mislocalization in other yeast mutant strains defective in late
endosome-Golgi transport, such as ypt6
,
snx4
, and vps26
cells, but not in
mutants defective in endocytosis, early endosome-Golgi transport, late
endosome-vacuole transport, and Golgi export. Thus, Btn2 may mediate
the retrieval of cargo molecules from late endosomes to the Golgi
apparatus. This effect is specific to certain Golgi proteins, as other
markers, such as Sed5
(36) and Sec7
(26), are not
mislocalized in the absence of BTN2. Similarly, Yif1 was
unstable in btn2
cells, while other transient and
resident Golgi markers were unaffected. Fourth, Btn2 immunoprecipitates
the Snx4 sorting nexin
(38) and components of
retromer, including Vps26 and Vps35, which confer late endosome-Golgi
transport (73,
74). In vitro binding
assays confirm a direct interaction between Btn2 and Snc1 or Vps26.
Since Btn2 interacts with components of the endosomal sorting machinery
and a known cargo protein is mistrafficked in btn2
cells, it suggests that Btn2 plays an important role in endosomal
protein sorting. We hypothesize that NCL onset and pathogenesis in
humans may occur as a consequence of the loss of the Btn2/Hook1
function in endosomal protein
sorting.
|
|
|---|
Growth tests. Yeast was grown on synthetic and rich-growth media (71). For growth tests on plates, yeast was grown to log phase, normalized for optical density at 600 nm, diluted serially, and plated by drops onto solid medium preincubated at different temperatures. Calcofluor resistance was measured by adding 50 to 150 µg/ml fluorescent brightener 28 (Sigma) per plate and plating serial dilutions of yeast by drops.
Two-hybrid assay. The yeast two-hybrid assay was performed as described by Durfee et al. (22), using Snc13-94 as the bait and a yeast cDNA library as the prey, with Y153 cells. Out of 900,000 transformants, 24 positives were identified, of which 1 was positive and conferred resistance to both 3-aminotriazole (3-AT) and ß-galactosidase activity. Cell growth in the presence of 25 mM 3-aminotriazole on synthetic medium lacking histidine, along with ß-galactosidase activity on nitrocellulose filters, was measured using standard procedures (22).
Yeast strains and plasmids.
Yeast
strains used are listed in Table
1. Standard yeast vectors included the
following: pAD11 (CEN HIS3), pRS313 (CEN
HIS3), pRS315 (CEN LEU2), pRS316
(CEN URA3), and YEp13M4 (2µm LEU2);
pRS426 (2µm URA3); pAD4
(2µm
LEU2 ADH1 promoter); and pAD54 and pAD6 (both are the
same as pAD4
but contain sequences encoding thehemagglutinin [HA] or myc epitope, respectively, downstream of the
ADH1 promoter). Plasmids used in this study are listed in
Table
2. A BTN2 deletion construct was created by first cloning a
PCR-amplified 4.3-kb genomic fragment of BTN2 (from
1,658 bp upstream of the start codon to +1,409 bp
downstream of the stop codon) into pGEM-T Easy (Promega) to yield
pGEM-BTN2. Next, pGEM-BTN2 was digested with BglII to remove a fragment
of the BTN2 gene corresponding to the base pair sequence
164 to 1,194 of the coding region. Following that, either a
LEU2 or a URA3 selectable marker was inserted into
the BglII site to yield pGEM-BTN2-LEU2 or pGEM-BTN2-URA3. To disrupt
BTN2, either pGEM-BTN2-LEU2 or pGEM-BTN2-URA3 was digested
with NotI and transformed into yeast. Integration at the BTN2
locus was verified by PCR. To create a two-copy GFP
[GFP(x2)] protein integration cassette for PCR amplification, plasmid
pFA6a-GFP(S65T)-His3MX6
(48) was cut with BamHI
and PacI, and a BamHI-PacI fragment of BTN2-GFP (derived from
pAD6-BTN2-GFP by PCR amplification and lacking the stop codon) was
inserted to yield plasmid pBTN2-GFP(x2)-His3MX6. Genomic tagging of
BTN2 with GFP(x2) to yield strain RKY7 was
accomplished by the transformation of BY4741 cells with the PCR product
obtained by amplifying plasmid pBTN2-GFP(x2)-His3MX6 with a forward
oligonucleotide specific to the 3' end of BTN2 and a
reverse oligonucleotide specific to the insertion cassette and the
3' untranscribed region of BTN2. Integration was
verified by PCR
analysis.
|
View this table: [in a new window] |
TABLE 1. Yeast
strains used in this study
|
|
View this table: [in a new window] |
TABLE 2. Plasmids
used for this study
|
Immunoprecipitation and Western analysis. Interactions between the HA- or myc-tagged Btn2 and other proteins present in cell lysates were monitored by immunoprecipitation (IP) from cell extracts, as described previously (17). However, the following changes were made to the lysis and IP buffers. TE (10 mM Tris-HCl, pH 7.5, EDTA 1 mM, NaCl 150 mM) was used instead of phosphate-buffered saline, and 0.5% NP-40 was used instead of Triton X-100. The following protease inhibitors were added: 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor, 10 µg/ml pepstatin, and 1 mM PMSF (phenylmethylsulfonyl fluoride). IP antibodies included anti-myc antibodies (3 µl per reaction; Santa Cruz Biotechnology, Santa Cruz, CA) and anti-HA antibodies (2.5 µl per reaction; Roche, Indianapolis, IN). Antibodies for protein detection in Western blots included polyclonal antibodies against carboxypeptidase Y (CPY), Mnn1, and Sec22 (gifts of S. Emr, UCSD, San Diego, CA); Kar2 (gift of C. Barlowe, Dartmouth University, Dartmouth, NH); Sec9 (gift of P. Brennwald, UNC, Chapel Hill, NC); Sed5 (gift of H. Pelham, MRC, Cambridge, United Kingdom); Snc1 (66); Sso1 (gift of S. Keranen, VTT, Espoo, Finland); Tlg1 (gift of H. Pelham, MRC, Cambridge, United Kingdom); Tlg2 (gift of H. Abeliovich, Faculty of Agriculture, HUJ, Rehovot, Israel); Vam3 (gift of A. Mayer, Université de Lausanne, Lausanne, Switzerland); Vam7 (gift of C. Ungermann, U. of Osnabrück, Osnabrück, Germany); Vti1 (gift of G. Fischer von Mollard, University of Göttingen, Göttingen, Germany); retromer (Vps26 and Vps35; gifts of M. Seaman, Cambridge Institute for Medical Research, Cambridge, United Kingdom); and monoclonal antibodies against the HA epitope (gift of M. Wigler, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), ß-actin (MP Biomedicals, Aurora, OH), Dpm1 (Molecular Probes, Eugene, OR), GFP (Roche, Indianapolis, IL), glutathione S-transferase (GST) (Calbiochem, Darmstadt, Germany), and His6 (Sigma-Aldrich, St. Louis, MO). Samples of total cell lysates (TCLs) (20 µg protein per lane) and immunoprecipitates obtained from 500 µg protein of lysate (per IP reaction) were resolved by electrophoresis and detected by Western blotting. Detection was performed by chemiluminescence.
Recombinant protein purification and in vitro binding assay. To perform in vitro binding assays, recombinant His6-Btn2, GST, GST-Snc1 (Snc12-94), GST-Snx4, GST-Vps17, GST-Vps26, GST-Tlg2 (Tlg22-318), and GST-Sso1 (Sso12-265) were generated with Escherichia coli strain BL21(DE3)-R3 from bacterial expression plasmids and purified using standard procedures. His6-Btn2 was purified using ProBond resin (Invitrogen, Carlsbad, CA) and a final elution with 200 mM imidazole, while GST-tagged proteins were purified using immobilized glutathione beads (Pierce, Rockford, IL) and a final elution with 50 mM glutathione. For binding, equal amounts of His6-Btn2 and GST-tagged proteins (10 µg each) were mixed together in binding buffer containing 0.1% NP-40 in phosphate-buffered saline (300 mM NaCl), pH 7.5. Following incubation at 4oC for 12 h, 50 µl of a 50% ProBond slurry in binding buffer was added, and the samples were incubated with rotation for an additional 2 h at 4oC. Then, samples were washed five times with binding buffer and eluted with the addition of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer prior to electrophoresis on 10% SDS-polyacrylamide gels.
|
|
|---|
900,000
transformants, one colony tested positive for both lacZ
expression and resistance to 3-AT in repetitive assays (data not
shown). DNA sequencing revealed that this clone carried the
BTN2 gene, which encodes a protein that is overproduced in
cells lacking BTN1, the yeast ortholog of the human
CLN3 Batten disease gene
(18,
59). Btn2 has been
suggested to be similar to Hook1
(12), a coiled-coil
protein of unclear function involved in endocytosis and protein sorting
of MVBs (45,
79,
86). Sequence alignments
performed using multiple sequence alignment with high accuracy and high
throughput (MUSCLE) (23)
indeed revealed that Btn2 from S. cerevisiae is orthologous to
Drosophila and human Hook1 (Fig.
1). Btn2 was found to be 18% and 22% identical and 32% and 33% homologous
to Drosophila and human Hook1, respectively, over its entire
length (410 amino acids).
![]() View larger version (78K): [in a new window] |
FIG. 1. BTN2
encodes a Hook1 ortholog as shown by MUSCLE alignments of Btn2 from
Saccharomyces cerevisiae (sc Btn2; GenBank accession no.
NP_011658.1), Drosophila Hook1
(dm Hook1; GenBank accession no.
NP_476573.1), and human Hook1 (hs Hook1;
GenBank accession no. NP_056972.1).
Amino acid identities shared between two or more alignments are shown
in black boxes, while similarities are shown in light (less similar)
and dark (more similar) gray boxes. Numbers correspond to the amino
acid, while periods indicate gaps introduced into the sequence by the
program.
|
![]() View larger version (67K): [in a new window] |
FIG. 2. Btn2
interacts with Snc1 and the yeast endocytic SNARE complex.
(A) Snc1 interacts with Btn2, as assayed using the two-hybrid
ß-galactosidase and 3-AT growth assays. Yeast (Y153 cells) were
transformed with plasmids expressing the Gal4 DNA binding domain fused
to Snc1 (pAS1-Snc1 ) and full-length Btn2 fused to the Gal4
transactivating domain (pACT-Btn2), together or alone. Transformants
were either grown as patches on plates and then replica plated onto
nitrocellulose fibers (left panel) or grown to mid-log phase in liquid
culture prior to serial dilution and plating by drops onto solid
medium (middle and right panels). In addition, positive
control (+control) cells
expressing Rb and PP1 from plasmids (pAS/N-RB and pPP1 ) were
used in parallel. For the ß-galactosidase
(ß-gal) assay, cells replica plated onto filters were lysed in
liquid nitrogen and measured for ß-galactosidase activity using
standard techniques. For assaying resistance to 3-aminotriazole (3-AT)
and growth in the absence of histidine, cells were plated onto either
control selective medium (SC-LT) or medium lacking histidine and
containing 25 mM 3-AT (SC-HLT +3-AT). Cells were grown for
60 h at 26°C. (B) The yeast endocytic SNARE
complex coimmunoprecipitates with Btn2. Wild-type yeast (W303-1a)
expressing HA-Btn2 from a multicopy plasmid (pAD54-Btn2) were
transformed with single-copy plasmids expressing myc-Snc1
(pHADH-myc-cSnc1) or myc-Snc2 (pHADH-myc-Snc2), or empty vector alone
(pAD11) as control. In addition, wild-type cells bearing a control
multicopy plasmid (pAD54) were transformed with the same single-copy
plasmids expressing myc-Snc1 or myc-Snc2 or an empty vector as
controls. Cells were grown to mid-log phase and processed for
immunoprecipitation with anti-HA antibodies. Precipitates (IP) formed
from each reaction mixture (500 µg total protein per reaction)
and TCLs (20 µg protein per lane) were resolved with SDS-PAGE
and detected by Western blotting with a variety of antisera. Shown are
blots detected with anti-HA antibody (1:7,000), which reveals that
HA-Btn2 is expressed as a doublet. Also shown are blots detected with
antisera to Tlg2 (1:1,000), Vti1 and Tlg1 (added together, 1:2,000 and
1:3,000, respectively), myc epitope (to detect myc-Snc1 or myc-Snc2,
1:1,000), Sed5 (1:3,000), Sso1/2 (1:3,000), and
Vam7 (1:5,000).
Based upon densitometric analysis of the individual Tlg1, Tlg2, and
Vti1 signals in the three HA-Btn2-containing IP lanes, we estimate that
an average of 4% of the endocytic SNARE complex
coimmunoprecipitated with HA-Btn2 in the reaction mixtures after
normalization for Btn2 precipitation (immunoprecipitated 3.8% Vti1,
3.1% Tlg1, and 4.2% Tlg2; data not shown). (C) Overexpression of
BTN2 enhances the growth of vti1-1 cells.
vti1-1 cells bearing a control vector (pAD54) or vectors
overexpressing HA-BTN2 or HA-VTI1 (pAD54-BTN2 or
pAD54-VTI1, respectively) were grown to mid-log phase at 26°C
before serial dilution (10x) and plating by drops onto
prewarmed solid medium. Plates were grown for 2 to 3 days at the
indicated temperatures before
photodocumentation.
|
As Btn2 interacts with components of the endocytic SNARE complex, we examined whether BTN2 interacts genetically with mutations in VTI1, a t-SNARE that facilitates multiple endosomal transport routes leading to the vacuole (i.e., from the Golgi apparatus to the late endosome/prevacuole, the late endosome/prevacuole to the vacuole, cytosol to the vacuole, and retrograde late endosome/prevacuole to the Golgi transport) (25). We found that the overexpression of HA-BTN2 significantly enhanced the growth of temperature-sensitive vti1-1 mutants (Fig. 2C), which are defective principally in Golgi-to-late endosome/prevacuole and cytosol-to-vacuole transport at restrictive temperatures. This improvement in growth was observed at all temperatures and was more robust than that conferred by VTI1 overexpression at 32oC and 35oC (Fig. 2C). In contrast, HA-BTN2 overexpression did not enhance the growth of either vti1-2 cells, which are defective in all Vti1-mediated steps except for late endosome/prevacuole-to-Golgi retrograde transport, or vti1-11 cells, which are defective in all steps (25). Thus, the restoration of growth mediated by BTN2 overexpression is allele-specific and suggests a possible role for Btn2 in Golgi-to-late endosome/prevacuole transport. A role in cytosol-to-vacuole transport appears less likely given that Btn2 does not interact with Vam7 (Fig. 2B).
Btn2 localizes to the late endosome/MVB compartment. We next examined the localization of Btn2 in yeast. We determined whether Btn2 resides on the endocytic pathway by expressing Btn2-GFP from a single-copy plasmid and performing colabeling with the vacuolar marker FM4-64 (85). We first pulse-labeled cells with FM4-64 on ice, followed by a short chase (5 to 20 min) at 26oC, in order to label early endocytic compartments, and followed localization of the two markers. Btn2-GFP labeling produced individual, large punctate structures that did not colocalize with FM4-64 at any interval during the short chase (Fig. 3A). However, we did see colabeling in these large structures in cells that were incubated with FM4-64 at 26oC and then chased for 30 min at 26oC, to allow for vacuolar labeling (Fig. 3A, bottom panels). Thus, Btn2 does not appear to localize to an early compartment of the endocytic pathway but more likely localizes to a compartment located adjacent to the vacuole. This pattern is similar to the labeling seen with late endosomes/MVBs. We note that the Btn2-labeled compartment was often located near the nucleus, as revealed by DAPI (4',6'-diamidino-2-phenylindole) staining (Fig. 3B). However, it did not overlap either with a nucleolar marker, Sik1, or with DAPI labeling itself (Fig. 3B). Thus, Btn2 appears to localize to the late endocytic pathway.
![]() View larger version (26K): [in a new window] |
FIG. 3. Btn2resides in a late endocytic compartment and colocalizes in parts with
Snx4, Tlg2, and Vps27 (arrowheads). (A) Btn2-GFP resides in a
late endocytic compartment. Wild-type cells (W303-1b) expressing
Btn2-GFP from a single-copy plasmid (pRS316-myc-BTN2-GFP) were grown to
mid-log phase on selective synthetic medium at 26°C. Cells were
either pulse-labeled with FM4-64 (5.4 µM final concentration)
on ice (45 min) and then chased for varying amounts of time (5 to 20
min) at 26°C or were pulse-labeled and chased (30 min) at
26°C. Elapsed chase times are shown in minutes ('). All
labeling was performed in the dark. Merge indicates the merger of the
GFP and FM4-64 fluorescence windows. (B) Btn2-GFP does not
localize to the nucleus. Top panels: wild-type cells (W303-1b)
expressing Btn2-RFP from a single-copy plasmid (pRS316-myc-BTN2-mRFP)
were grown to mid-log phase on selective synthetic medium at
26°C, labeled briefly with Hoechst dye (50 µg/ml
Hoechst 33342 for 10 min at room temperature; Molecular Probes), and
visualized by confocal microscopy. Bottom panels: SIK1-RFP
cells (ATCC 201389) were transformed with a single-copy plasmid
(pRS316-myc-BTN2-GFP) expressing Btn2-GFP. Cells were grown to mid-log
phase at 26°C and visualized by confocal microscopy. Merge
indicates the merger of GFP and RFP or RFP and DAPI fluorescence
windows. (C) Btn2-RFP colocalizes in part with the Snx4,
Tlg2, and Vps27 endosomal markers (arrowheads). Wild-type cells
(W303-1b) expressing Btn2-RFP from a single-copy plasmid
(pRS313-myc-BTN2-mRFP) were transformed with plasmids expressing
GFP-tagged forms of Snx4 (pAD54-GFP-SNX4), Vps27 (pGO426-GFP-VPS27),
Tlg2 (pRS315-GFP-TLG2), Snc1 (pADHU-GFP-cSNC1), Tlg1 (pRS315-GFP-TLG1),
Vps10 (pAD54-VPS10-GFP), and Yif1 (pRS316-GFP-YIF1) (see Table
2 for plasmid details).
Cells were grown to mid-log phase at 26°C on selective
synthetic medium prior to visualization by confocal microscopy.
btn2 cells (RKY4) were used to coexpress GFP-Yif1
(pRS316-GFP-YIF1) and Btn2-RFP (pRS313-myc-BTN2-mRFP), instead of
wild-type cells. Merge indicates the merger of the GFP and RFP
fluorescence
windows.
|
cells (Fig.
3C, compare to GFP-Yif1
localization in btn2
cells in Fig.
5A). Together, the results
imply that Btn2 has an endosomal pattern of localization most similar
to that of the late endosome/MVB. This pattern corresponds with that
predicted for Hook1 in Drosophila and mammals
(45,
69,
79). However, we note
that Btn2 did not colocalize with Vps10-GFP (Fig.
3C), the CPY receptor that
cycles through a late endosomal compartment to deliver CPY to the
vacuole (19). This may
indicate either that yeast cells contain multiple late endosomal
compartments or that the late endosome is composed of separate domains.
We also note that an earlier study demonstrated cytosolic labeling for
Btn2-GFP (13); however,
we were unable to recapitulate these results.
![]() View larger version (50K): [in a new window] |
FIG. 5. Yif1
is mislocalized to the vacuole in btn2 ,
rhb1 , vps26 ,
snx4 , chs4 , tlg2 ,
and ypt6 cells. (A) GFP-Yif1 is
mislocalized to the vacuole in btn2 ,
chs4 , rhb1 , snx4 ,
tlg2 , vps26 , and
ypt6 cells. A single-copy plasmid expressing GFP-Yif1
(pRS316-GFP-YIF1) was transformed into wild-type (WT) cells (both
Euroscarf and W303-1b strains tested; Euroscarf cells shown) or cells
bearing mutations of BTN2 (both Euroscarf and RKY4
btn2 strains tested; Euroscarf cells shown),
RHB1 (both Euroscarf and JU28-1 rhb1 strains
examined; Euroscarf strain shown), CHS4, VPS26,
YPT6, SNX4, TLG2 VAM6, END4
(RH268-1c), RIC1, VPS51, and SEC7 (RSY979).
Cells were grown to mid-log phase at 26°C on selective
synthetic medium prior to pulse-labeling with FM4-64 (5.4 µM
final concentration; 30 min at 26°C) and chase (30 min at
26°C) before visualization using confocal microscopy.
sec7-5 (RSY979) cells were grown to mid-log phase at
26°C (permissive temperature) and either maintained and labeled
with FM4-64 at 26°C or shifted to 37°C for 30 min prior
to pulse-labeling with FM4-64 (30 min; 37°C) and chase (30 min;
37°C) before visualization. Note labeling of the vacuole by GFP
in btn2 , chs4 ,
rhb1 , snx4 , tlg2 ,
vps26 , and ypt6 cells. See Table
3 for statistics regarding
either Golgi or vacuolar GFP-Yif1 localization in the various strains
examined. Merge indicates the merger of the GFP and FM4-64 fluorescence
windows. (B) Btn2 and Btn2-GFP restore RFP-Yif1 localization
to btn2 cells. btn2 cells
expressing RFP-Yif1 from a multicopy plasmid (pAD54-RFP-YIF1) were
transformed with either a control plasmid (pRS313) or single-copy
plasmids expressing Btn2 or Btn2-GFP (pRS313-BTN2 or pRS313-BTN2-GFP).
Cells were grown to mid-log phase at 26°C prior to
visualization. Merge indicates the merger of light and fluorescence
microscopy
images.
|
)
(2,
40,
47) protein recycling and
export from endosomes (i.e., rcy1
,
chs4
, gcs1
, and
snx4
)
(28,
38,
84), MVB formation (i.e.,
vps23
and vps27
)
(41,
42), Golgi export (i.e.,
sec7-5 at 37oC)
(26), COPI-mediated
retrograde transport (i.e., sec21-2, sec27-1, and
sec33-1) (20,
21,
46), and others (i.e.,
rsg1/rhb1; both Euroscarf and JU28-1 rhb1
strains tested) (83). We
noted that there were more numerous and smaller Btn2-GFP-labeled
structures in some cell types, particularly snc
cells
which are defective in both endo- and exocytosis and have fragmented
vacuoles (34,
66). Overall, though,
Btn2-GFP localized to large perivacuolar structures in all transport
mutants, suggesting that defects in intracellular protein sorting do
not greatly affect Btn2 localization.
![]() View larger version (30K): [in a new window] |
FIG. 4. Btn2
localization is not altered in cells deficient in endocytosis and
endosomal protein sorting. (A) Btn2 localization is not
altered in cells deficient in endocytosis and endosomal protein
sorting. A single-copy plasmid (pRS316-myc-BTN2-GFP) expressing
Btn2-GFP was transformed into wild-type (WT) cells (W303-1b) or a
variety of yeast mutants. The latter includes strains bearing deletions
of RCY1, CHS4, GCS1, RHB1 (both
Euroscarf and JU28-1 rhb1 strains tested;
Euroscarf strain shown), SNC1, SNC1/2
(snc ; JG8 T15:85), VPS23,
VPS27, or VPS28, as well as strains
bearing temperature-sensitive mutations in
genes SEC27 (RSY1312), SEC33 (RDY260), and
SEC21 (RSY1309) COPI subunits or in END4
(RH268-1c). Cells were grown to mid-log phase at 26°C
(permissive temperatures) on selective synthetic medium prior to
visualization by confocal microscopy. (B) The colocalization between
Btn2 and Snx4 or Vps27 is not altered in vps27 and
snx4 cells, respectively. vps27 and
snx4 cells expressing Btn2-RFP from a single-copy
plasmid (pRS313-myc-BTN2-mRFP) were transformed with plasmids
expressing either GFP-Snx4 (pAD54-GFP-SNX4) or GFP-Vps27
(pGO426-GFP-VPS27), respectively. Merge indicates the merger of the GFP
and RFP fluorescence windows. (C) Btn2-GFP(x2) expressed from the
genomic BTN2 locus labels multiple large compartments. Yeast
bearing BTN2 tagged with GFP(x2) at its
genomic locus (RKY7 cells) were grown to mid-log phase at 26°C
prior to visualization by confocal microscopy. Merge indicates the
merger between the light microscopy and GFP fluorescence
windows.
|
and
snx4
cells, respectively (Fig.
4B). As predicted from
Fig. 4A, no change in the
localization of Btn2-RFP was found, and likewise, no change in the
abilities of Btn2 and either Vps27 or Snx4 to colocalize was observed.
Finally, we examined the localization of Btn2-GFP(x2) expressed from
its genomic locus under the native promoter (Fig.
4C). We found that few
cells (
3%) had significantly visible GFP labeling, but all
cells that did had a pattern of localization very similar to that
observed for either Btn2-GFP or Btn2-RFP expressed from single-copy
plasmids. We note that Btn2-GFP expressed from its genomic locus by the
native promoter and bearing only one copy of GFP did not yield visible
labeling (data not shown).
Retrieval of Yif1 to the Golgi apparatus is blocked in btn2
cells.
Because Btn2 has
homology to Hook1 (Fig.
1), localizeslate on the endocytic pathway (Fig.
3), and interacts with
SNAREs involved in endocytic retrieval (Fig.
2), we examined whether
the deletion of BTN2 regulates the intracellular trafficking
of proteins. We first examined the localization of Yif1, a Golgi
protein involved in the recruitment of Ypt1 and the consumption
of COPII vesicles
(51). This protein was
demonstrated to mislocalize to the vacuole in btn2
cells (14), although the
manner and mechanism were not resolved. We found that GFP-tagged Yif1
(GFP-Yif1) expressed from a single-copy plasmid gave punctate
Golgi-like labeling in wild-type cells (Fig.
5A), as previously shown
(14,
51). We examined Yif1
localization in a variety of cell types, including cells lacking
BTN2 or RSG/RHB1, a small GTPase of unknown function
(83) that was found to
interact with Btn2, using the yeast two-hybrid screen
(13). Interestingly,
instead of the punctate labeling seen in wild-type cells, GFP-Yif1 was
found to accumulate in the vacuole in both btn2
and
rhb1
cells (Fig.
5A; Table
3). This effect was observed in the Euroscarf btn2
and
rhb1
deletion mutants, as well as in the RKY4
btn2
and JU28-1 rhb1
strains (data
not shown). GFP-Yif1 mislocalization was also observed in other cells
defective in endosomal protein sorting. For example, cells lacking
CHS4, which encodes a protein required for the efficient
export of chitin synthase III (Chs3) from endosomes
(84), or those lacking
YPT6, which encodes a small GTPase involved in endosome-Golgi
and intra-Golgi transport
(81) gave identical
patterns of localization (Fig.
5A). Likewise, cells
bearing a deletion of VPS26, which encodes a component of the
retromer complex that resides on late endosomes and mediates late
endosome-Golgi transport
(73,
74), gave the same
pattern (Fig. 5A).
Finally, cells lacking SNX4, which encodes a sorting nexin
required for endosome-Golgi transport
(38), or TLG2,
which encodes a t-SNARE involved in both endocytosis and endosomal
transport (2,
40) and which binds Btn2
(Fig. 2B), mislocalized
GFP-Yif1 to the vacuole (Fig.
5A). Thus, many cellular
components known to confer protein sorting and retrieval from endosomes
to the Golgi apparatus affect GFP-Yif1 localization and recycling to
the Golgi apparatus. We note that some mutations had more dramatic
effects upon GFP-Yif1 localization. For example, the relative amount of
mislocalization observed (based upon counting cells with
vacuole-localized GFP-Yif1) was rhb1
btn2
ypt6
snx4
vps26
>
snc1
> tlg2
>
snc2
chs4
>>
vps10
wild-type cells (Table
3). Interestingly, the
deletion of VPS10, which confers CPY trafficking to the
vacuole via late endosomes in a retromer-dependent manner
(73,
74), had no effect on
GFP-Yif1 localization (Table
3). This suggests that
Vps10 is not involved in Yif1 retrieval.
|
View this table: [in a new window] |
TABLE 3. Localization
of GFP-Yif1 in yeast
|
and
vps51
cells)
(6,
16,
68,
75), late
endosome-vacuole transport (e.g., vam6
cells)
(55), and Golgi export
(e.g., sec7-5 cells at 37oC)
(26) (Fig.
5A). We note that the
vacuoles observed in ric1
and vps51
cells are fragmented, while they are apparently absent from
vam6
cells, as detected using FM4-64 labeling.
Nonetheless, GFP-Yif1 does not access the FM4-64-labeled compartments
in these cells. Together, the results suggest that Btn2, along with
Rhb1, functions upon a late endosome-to-Golgi recycling pathway that is
regulated by Ypt6, Snx4, and retromer.
To verify the
functionality of Btn2-GFP, we examined its ability to confer RFP-Yif1
trafficking in btn2
cells (Fig.
5B). RFP-Yif1 is
functional as its expression was shown to confer temperature-resistant
growth to yif1-2 cells at restrictive temperatures (data not
shown). In cells lacking BTN2, we found that RFP-Yif1
expressed from a single-copy plasmid mislocalized to large structures
that corresponded to vacuoles, as seen for GFP-Yif1 in Fig.
5A. In contrast, RFP-Yif1
labeling appeared as numerous small punctate structures in cells
expressing either Btn2-GFP or Btn2 from single-copy plasmids. Our
results imply that Btn2-GFP is functional and can correct Yif1
mislocalization.
Golgi-, endosome-, and vacuole-targeted proteins are not generally mislocalized in btn2
cells.
As Btn2 appears necessary for GFP-Yif1
and RFP-Yif1 recycling, we examined whether other proteins are
mistrafficked in btn2
cells. We first examined
whether GFP-Snc1 undergoes normal recycling from early endosomes to the
Golgi apparatus (47). We
examined the localization of GFP-Snc1 expressed from a single-copy
plasmid in btn2
cells (both Euroscarf and RKY5
btn2
strains were examined), as well as
rcy1
and end4-1 cells, which served as
positive controls for retention to early endosomes and for inhibition
of internalization, respectively
(28,
47). We found that
GFP-Snc1 primarily labeled the bud plasma membrane as well as small
internal punctate structures that correspond to early endosomes and
trans Golgi structures
(47,
70) in both
btn2
cells and wild-type yeast (Fig.
6A). In contrast, GFP-Snc1 labeled the surface of both the mother and the
bud in cells defective in endocytosis (e.g., end4-1 cells;
Fig. 6A), as seen earlier
(28,
70). Likewise, GFP-Snc1
gave punctate labeling corresponding to the early endosomes in
rcy1
cells (Fig.
6A), also as seen earlier
(28,
70). These results
suggest that there is no significant deficiency in the endosomal
sorting and retrieval of Snc1 in the absence of Btn2.
![]() View larger version (41K): [in a new window] |
FIG. 6. The
localization of GFP-tagged Snc1, Fur4, and Ste2 is unaltered in
btn2 cells. (A) GFP-Snc1 localization is
unaltered in btn2 cells. Wild-type (Euroscarf and
W303-1b strains tested; Euroscarf cells shown), btn2
(Euroscarf and RKY5 btn2 strains examined; Euroscarf
shown), end4-1, and rcy1 cells expressing
GFP-Snc1 from a single-copy plasmid (pRS315-GFP-cSNC1) were grown to
mid-log phase on synthetic selective medium at 26°C prior to
visualization by confocal microscopy. (B) Fur4-GFP
localization is unaltered in cells lacking BTN2. Wild-type
(Euroscarf and W303-1b strains tested; Euroscarf cells shown)
and btn2 (Euroscarf and RKY4 btn2
strains examined; Euroscarf cells shown) cells expressing Fur4-GFP from
a single-copy plasmid (pRS316-FUR4-GFP) were grown to mid-log phase on
synthetic selective medium at 26°C prior to pulse-labeling with
FM4-64 (5.4 µM final concentration; 30 min at 26°C) and
chase (30 min at 26°C) before visualization using confocal
microscopy. (C) Ste2-GFP localization is unaltered in cells
lacking BTN2. Wild-type (W303-1b) and btn2
(RKY5 btn2 strain examined) cells expressing Ste2-GFP
from a single-copy plasmid (pRS314-STE2-GFP) were grown to mid-log
phase on synthetic selective medium at 26°C prior to
pulse-labeling with FM4-64 (5.4 µM final concentration; 30 min
at 26°C) and chase (30 min at 26°C), before
visualization using confocal microscopy. Merge indicates the merger of
GFP and FM4-64 (B and C) fluorescence microscopy
images.
|
(Euroscarf and RKY4 btn2
strains) cells expressing GFP-Fur4 from a single-copy plasmid, we
observed GFP-Fur4 labeling of the plasma membrane and the vacuole,
where Fur4 is degraded (Fig.
6B). Thus, Fur4
trafficking appears to be normal in btn2
cells.
Next, we examined the localization of Ste2-GFP, the yeast
-mating factor receptor, which undergoes internalization and
trafficking to the vacuole in a ligand-dependent fashion
(77). In untreated
wild-type cells, we found Ste2-GFP present on both the plasma and the
vacuolar membranes (Fig.
6C), as we reported
previously (34). Similar
results were obtained with btn2
(RKY4) cells (Fig.
6C), implying that Btn2
does not alter the ability of Ste2 to reach either
membrane.
Finally, we examined the localization of other proteins
that are known to reside in the Golgi apparatus and endosomal
compartments or are to be trafficked to the vacuole, in
btn2
cells. We examined GFP-tagged proteins,
including Tlg1, Tlg2, Snx4, Vps27, Vps10, CPY, and CPS in
btn2
cells (Euroscarf and RKY4 btn2
strains) but found no changes in their patterns of localization (Fig.
7). In addition, we examined the localization of Golgi markers, including
the Sed5 t-SNARE (GFP-Sed5), which labels the cis Golgi
location (36), and the
Sec7 Arf exchange factor (Sec7-RFP), which labels the trans
Golgi location (26).
However, neither of these markers were mislocalized in
btn2
cells (Fig.
7). Thus, the integrity of
the Golgi and the endosomal and vacuolar trafficking pathways is intact
in btn2
cells. The principle defect observed in cells
lacking BTN2, therefore, is the apparent failure to retrieve
Yif1 to the Golgi apparatus (Fig.
5). Together, these
results imply that Btn2 is probably involved in protein export from a
late endosomal compartment. This effect is specific to certain cargo
proteins, as neither CPS nor CPY trafficking (trafficking through late
endosomes) is affected in btn2
cells.
![]() View larger version (38K): [in a new window] |
FIG. 7. The
deletion of BTN2 does not affect the trafficking of a wide
variety of other endosomal cargo proteins. Wild-type (WT) and
btn2 cells expressing CPY-GFP [pGAL
BglII-CPY(1-50)GFP], CPS-GFP (pGO426-CPS1-GFP), GFP-Snx4
(pAD54-GFP-SNX4), GFP-Vps27 (pGO426-GFP-VPS27), Vps10-GFP
(pAD54-VPS10-GFP), GFP-Tlg1 (pRS315-GFP-TLG1),
GFP-Tlg2 (pRS315-GFP-TLG2),
GFP-Sed5 (pRS315-GFP-SED5), or Sec7-RFP were grown
to mid-log phase on synthetic selective medium at 26°C prior to
visualization by confocal microscopy. Protein expression was performed
using the Euroscarf wild-type and btn2 cells, except
in the case of CPS-GFP expression, which was performed with W303-1b and
RKY4 btn2 cells, and Sec7-RFP expression, which was
performed using the W303-1a-SEC7-RFP and RKY6
strains.
|
cells.
Since GFP-Yif1 appears mislocalized to
the vacuole in btn2
cells and in cells defective in
late endosome-Golgi trafficking (Fig.
5), we examined whether it
is indeed degraded therein. By Western analysis, we determined that
more GFP-Yif1 is found in its various smaller (degraded) forms in
btn2
cells than in wild-type cells, as detected using
anti-GFP antibodies (Fig.
8A). In the representative experiment shown, 68% of GFP-Yif1
was present as degradation products, compared to 27% in wild-type
cells, after normalization for expression. In contrast, the levels of
other proteins known to reside in or transit through the Golgi
apparatus (i.e., Mnn1, Sec22, Bet1, and CPY) were basically unchanged
in btn2
cells (Fig.
8A). Likewise, the levels
of an ER marker, Dpm1, and a cytosolic marker, actin, were also
unchanged (Fig. 8A). Thus,
GFP-Yif1 that is not recycled to the Golgi apparatus is probably
degraded in the vacuole in btn2
cells. This explains
why the vacuolar lumen and not the limiting vacuolar membrane is
labeled by GFP-Yif1 or RFP-Yif1 in btn2
cells and
other cells deficient in late endosome-Golgi sorting (Fig.
5).
![]() View larger version (47K): [in a new window] |
FIG. 8. Btn2
interacts with a complex containing Yif1, Snx4, and retromer.
(A) GFP-Yif1 is more degraded in cells lacking BTN2.
Wild-type (WT) (W303-1b) and btn2 (RKY4) cells
expressing GFP-Yif1 (GFP-Yif1) from a single-copy plasmid
(pRS316-GFP-YIF1) were grown to mid-log phase and lysed. Equal amounts
of protein from TCLs were subjected to SDS-PAGE and Western analysis
with antibodies against GFP (1:1,000; left panel) to detect both GFP
and GFP-Yif1, and intermediates. In the right panels, antibodies
against CPY (1:1,000), Mnn1 (1:1,000), Dpm1 (1:1,000), Sec22 (1:1,000),
Bet1 (1:1,000), and actin (1:10,000) were used. (B) Btn2
coimmunoprecipitates with Vps26 and Vps35. Wild-type,
vps17 , and vps26 cells (all
Euroscarf strains) expressing myc-Btn2-RFP from a single-copy plasmid
(+) (pRS316-myc-Btn2-mRFP) or bearing a control vector
() (pRS316) were grown to mid-log phase and processed for
immunoprecipitation. Samples from the TCLs and precipitates (IP) were
resolved by SDS-PAGE and detected in blots with anti-Vps26 (1:1,000),
anti-Vps35 (1:1,000), and anti-myc (1:1,000) antibodies. (C)
Btn2 coimmunoprecipitates with Snx4. Wild-type yeast (BY4741)
expressing myc-Btn2 from a single copy plasmid (+)
(pRS316-myc-Btn2-mRFP) or bearing
a control vector () (pRS316) were transformed with plasmids
expressing GFP-Snx4 (pAD54-GFP-SNX4), GFP-Yif1
(pAD54-GFP-YIF1), GFP-Snc1 (pAD54-GFP-cSNC1), or a
control vector () (pAD54). Cells were grown to mid-log
phase and processed for immunoprecipitation. Samples from the TCLs and
precipitates were resolved by SDS-PAGE and detected in blots with
anti-GFP (1:1,000) and anti-myc (1:1,000) antibodies. (D)
His6-Btn2 binds directly to GST-Snc1 and GST-Vps26.
Pull-down experiments (left panels) were performed by mixing equal
amounts of protein (10 µg) of purified recombinant
His6-Btn2 and GST-tagged Snx4, Vps17, Vps26, Tlg2, Snc1, and
Sso1, and GST alone. After binding, nickel-charged beads were used to
precipitate complexes which were resolved by SDS-PAGE and detected by
anti-GST (1:500) or anti-His6 (1:1,000) antibodies.
Arrowheads indicate the detection of GST-Vps26 and GST-Snc1 in the
blots. Samples (10 µg) of the purified recombinant proteins
(input; right panels) were also resolved by SDS-PAGE and detected with
anti-GST (1:500) or anti-His6 (1:1,000) antibodies.
Arrowheads indicate the appropriate full-length recombinant
proteins.
|
cells do not secrete CPY or Kar2 and are calcofluor sensitive.
Although the
deletion of BTN2 does not affect the trafficking (Fig.
7) of CPY-GFP or its
receptor, Vps10 (19),
nonetheless, a portion of CPY may be secreted outside the cell, as seen
with vps mutants. To examine this, we grew wild-type,
btn2
, and control vps cells on
nitrocellulose filters and examined them for the presence of CPY by
immunoblotting. However, CPY was not detected on filters at levels
different than those seen with wild-type cells, while it was secreted
by the control vps cells (data not shown). Next, we examined
whether cells lacking BTN2 are defective for the retention of
Kar2 to the ER by using immunoblotting
(5). Defects in the
Golgi-ER retrograde transport typically seen in COPI mutants
(20,
21,
46) lead to Kar2
secretion onto filters. However, we found that Kar2 was not secreted
onto nitrocellulose filters from cells lacking BTN2, unlike
sec21-2 and sec33-1 control cells (data not shown).
Thus, the lack of Btn2 does not lead to obvious defects in retrograde
transport early in the secretory pathway, nor does it abolish proper
CPY trafficking to the vacuole.
btn2
cells have
no obvious defects in protein secretion or growth, indicating that the
secretory pathway is not generally altered in the absence of this
factor
(58-60;
our unpublished observations). Nevertheless, to examine whether protein
export from early endosomes is generally affected, we determined
whether btn2
cells are sensitive to calcofluor, a
molecule which binds to chitin and inhibits growth. Cells in which Chs3
delivery to the plasma membrane is blocked are resistant to calcofluor
(84). This assay has been
used to identify mutants inhibited in Chs3 export from early endosomes
(i.e., chs4
) as well as compensatory suppressor
mutations (84). We
examined whether btn2
and other mutants are sensitive
to calcofluor. We found that unlike control chs4
cells, btn2
cells and other yeast cells (i.e.,
rhb1 cells) remain sensitive to increasing concentrations of
calcofluor (data not shown). Thus, btn2
and
rhb1
cells are unlikely to be significantly defective
in Chs3 export from early endosomes.
Btn2 coimmunoprecipitates retromer components and Snx4.
As Btn2 is predicted to act upon the
retrieval of specific cargo molecules (i.e., Yif1, but not Vps10) from
the late endosome to the Golgi apparatus, we examined whether it
interacts with retromer, a protein complex composed of Vps5, -17, -26,
-29, and -35 that confers Vps10 endosome-Golgi recycling
(73,
74). myc-tagged Btn2 was
used to precipitate proteins from both wild-type cells and cells
bearing mutations in retromer (e.g., vps17
and
vps26
cells), using anti-myc antibodies. We employed
the latter strains in case Btn2 was more tightly held in a complex with
retromer under conditions where retromer disassembly might be
compromised. Indeed, myc-Btn2 was able to precipitate components of
retromer, including native Vps26 and Vps35 (Fig.
8B). This interaction was
apparent in both wild-type cells and vps17
cells but
was abolished in vps26
cells (Fig.
8B). This suggests that
Btn2 is a novel interacting component with retromer and that the
interaction therewith may depend upon Vps26 and/or retromer
assembly.
In parallel, we examined immunoprecipitates for the presence of GFP-tagged Vps10, the CPY receptor known to interact with retromer (19), in lysates derived from cells overexpressing Vps10-GFP but observed no physical interaction with myc-Btn2 (data not shown). Since the deletion of BTN2 does not alter Vps10 or CPY trafficking (Fig. 7) and Btn2 does not colocalize with Vps10 in wild-type cells (Fig. 3C), we suggest that Btn2 may be part of a retromer-mediated trafficking complex independent of Vps10.
Next, we examined whether Snx4, which interacts with retromer components and is involved in endosome-Golgi recycling of Snc1 (38), binds to Btn2. We found that myc-Btn2 was able to precipitate GFP-tagged Snx4 from wild-type cells, along with GFP-Yif1 and GFP-Snc1, which served as controls (Fig. 8C). Thus, Btn2 may form a complex with a sorting nexin and the retromer coat in order to retrieve proteins (i.e., Yif1) to the Golgi apparatus.
His6-Btn2 interacts directly with GST-Snc1 and GST-Vps26.
To test whether Btn2 interacts directly
with individual SNAREs, retromer components, and Snx4, we produced
recombinant His6-tagged Btn2 in E. coli and
determined whether it could bind to recombinant GST-tagged SNAREs
(i.e., GST-Snc1, GST-Tlg2, and GST-Sso1), retromer components (i.e.,
GST-Vps17, and GST-Vps26), and GST-Snx4 in vitro. His6-Btn2
purified from bacteria ran as a single band of
60 kDa with
SDS-PAGE (Fig. 8D, far
right panel). This indicates that recombinant His6-Btn2 is
not modified, in contrast to HA-Btn2 which appears as a doublet in
yeast extracts (Fig. 2B).
We note that similar results were found for another Snc
v-SNARE-interacting protein, Vsm1
(49), though the nature
of these modifications is unknown. Purified GST-tagged proteins of the
correct molecular mass were also produced, although some degradation
products were apparent in the different preparations (Fig.
8D, right panels). All
recombinant SNAREs contained their soluble amino-terminal portions and
SNARE binding motifs but lacked their transmembrane domains.
In an in vitro binding assay, we mixed equal amounts of His6-Btn2 and the individual GST-tagged proteins, performed pull-downs with nickel beads, and separated the bound products with SDS-PAGE. We found that His6-Btn2 did not bind to GST alone but bound to both GST-Snc1 and GST-Vps26 specifically (Fig. 8D, left panels). Densitometric analysis of His6-Btn2 binding to GST-Snc1 or GST-Vps26 showed that it bound equally well to both and suggests that the affinity of Btn2 for either the v-SNARE or the retromer component is fairly similar. In contrast, His6-Btn2 did not bind to other SNAREs (i.e., GST-Tlg2 or GST-Sso1), GST-Vps17, or GST-Snx4 (Fig. 8D, left panels) individually. Together with the immunoprecipitation data (Fig. 2B and 8B and C), this suggests that Btn2 interacts with specific components of a complex involved in Yif1 sorting from late endosomes to the Golgi apparatus but not with all members of the complex.
|
|
|---|
BTN2 encodes a Hook1 ortholog (Fig.
1) that is a late
component of the endocytic pathway (Fig.
3A) and which localizes
adjacent to the vacuole but is clearly nonnuclear (Fig.
3A and B). Btn2, along
with the Rhb1 small GTPase, appears to play a prominent role in the
recycling of Yif1, as the deletion of either gene results in Yif1
missorting to the vacuole (Fig.
5; Table
3). Thus, we propose that
both Btn2 and Rhb1 mediate late endosome-Golgi recycling. This is
supported by several lines of evidence. First, known late
endosome-Golgi trafficking mutants, such as the vps26
strain, have a similar effect upon Yif1 sorting (Fig.
5A; Table
3), and GST-Vps26 binds
directly to His6-Btn2 in in vitro binding assays (Fig.
8D). VPS26
encodes a component of retromer, a pentameric complex composed of Vps5,
Vps17, Vps26, Vps29, and Vps35
(73,
74). Retromer regulates
the trafficking of the CPY receptor, Vps10, and retrieves it from the
late endosome to the Golgi apparatus. Vps26 has been proposed to link
both cargo selection and retromer assembly, while other retromer
components, Vps5 and Vps17, form a membrane-associated subcomplex and
are the yeast equivalents of sorting nexins 1 and 2 (Snx1 and -2)
(73,
74). These and other
retromer components have all been shown to localize to the late
endosome (73,
74). Second, Btn2
localizes to large perivacuolar structures that are consistent with
late endosomes (Fig. 3 and
4). Btn2 colocalizes in
part with the sorting nexin Snx4, the Vps27 late endosome/MVB marker,
and the Tlg2 endosomal t-SNARE to these same structures located
adjacent to the vacuole (Fig.
3C). Third, Btn2
coimmunoprecipitates with Yif1, Snx4, and retromer (Fig.
8B,C), along with an
endosomal SNARE complex (Fig.
2B), suggesting that it
may be a component of an assembled retromer-mediated Yif1 sorting
complex. Finally, in vitro binding studies (Fig.
8D) show that recombinant
Btn2 binds to specific components of this putative complex, including
the recycling v-SNARE, Snc1, which recycles from early endosomes to the
Golgi apparatus (47) and,
by inference from this work, from late endosomes to the Golgi
apparatus. In addition, recombinant Btn2 binds to Vps26, which is
involved in retromer assembly and cargo sorting
(73). Thus, we propose
that Btn2 confers cargo retrieval (i.e., Yif1 and, possibly, SNAREs)
from late endosomes to the Golgi apparatus along with
retromer.
Interestingly, neither CPY nor Vps10 trafficking was
affected by the deletion of BTN2 (Fig.
7), although both should
access the late endosome on their way to the vacuole in a
retromer-dependent fashion
(19,
73,
74,
78). This may imply that
there are multiple retromer-mediated cargo sorting events occurring at
the late endosome or perhaps that there are multiple late endosomal
compartments serviced by retromer
(7,
8). In either case, some
may be mediated by Btn2 and others may not, although at this point we
cannot distinguish between these two distinct possibilities. Despite
this, we were able to show that Btn2 forms complexes with Yif1,
retromer, and Snx4 but not with Vps10 (Fig.
8B and C and data not
shown). This is consistent with the idea that there are distinct
nexin-retromer sorting complexes operating in yeast. That neither Snc1
recycling from early endosomes to the Golgi apparatus (Fig.
6A) nor protein export to
the plasma membrane (as assayed by calcofluor sensitivity and growth
assays [data not shown]) are affected in btn2
cells
suggests that the role of Btn2 is limited to regulating the trafficking
of specific cargo molecules from a late endosome to the Golgi
apparatus. This is supported by the other physical interaction,
colocalization, and protein trafficking data presented here. Models
outlining the trafficking functions mediated by Btn2 in wild-type cells
and the consequences of BTN2 disruption therein are shown
(Fig.
9).
![]() View larger version (29K): [in a new window] |
FIG. 9. A
model for Btn2 function in late endosome-Golgi protein sorting.
Wild-type cells: the Snc1 exo/endocytic v-SNARE (blue) and Fur4 (red)
are both endocytosed and delivered by endocytic vesicles to the early
endosome (EE). Snc1 is delivered to the trans Golgi location
in a manner dependent upon Snx4, Rcy1, Ric1, and Ypt31/32, etc. (later
components are not listed). Fur4 is trafficked to the late endosome
(LE) for either recycling to the plasma membrane or delivery to the
vacuole for degradation. Retrieval to the plasma membrane is presumably
mediated by high-density secretory vesicles (HDSVs), which originate
from late endosomes (35,
37). A Golgi marker, Yif1
(purple), exits the Golgi apparatus to the late endosome but is
retrieved in a retromer-, Snx4-, and Btn2-dependent fashion back to the
Golgi apparatus. Vps10 (green), the CPY receptor, is also recycled to
the Golgi apparatus from a late endosome via retromer and Snx4 but in a
manner independent of Btn2. btn2 cells: in the
absence of BTN2, the recycling of Yif1 (but not the other
tested Golgi markers, e.g., Sed5 and Sec7) to the Golgi apparatus is
blocked and the protein is sent to the vacuole for degradation. The
endosomal sorting of Vps10, Snc1, and Fur4 is unaffected in the absence
of Btn2. Thus, we predict that Btn2 acts, along with retromer and Snx4,
to mediate the retrieval of Yif1 from a sorting late endosome back to
the Golgi
apparatus.
|
cells (Fig.
5A). More work is clearly
necessary to determine the temporal order of events leading to the
assembly of the putative retrieval complex in which Btn2 functions,
along with retromer, Snx4, and SNAREs. Finally, there is a connection
to COPI which bears future exploration. First, systematic interaction
studies have demonstrated that Sec27, a COPI component, and Btn2
interact physically (39).
Second, a role for COPI in late endosome-MVB sorting events has been
described for mammalian cells
(3,
24,
33,
87). Third, we recently
demonstrated a potential role for specific COPI subunits (COPI B)
(52), including Sec27, in
the delivery of CPS, Ste2, Ste3, and Fur4 to multivesicular bodies in
yeast (27). Fourth,
retromer components cosediment with COPI-coated membranes when
separated by size exclusion chromatography
(74). Finally, work in
progress suggests that Btn2 interacts genetically and physically with
COPI B components (R. Kama and J. E. Gerst, unpublished
results). Thus, Btn2 might function in conjunction with COPI, as well
as with retromer, in mediating specific post-Golgi trafficking
events. Previous studies have shown that Btn2 interacts with a wide variety of proteins (i.e., Rhb1, Yif1, and Ist2) (13, 14, 43) purportedly involved in numerous processes relevant to cell growth and homeostasis (i.e., ion, pH, or amino acid balance). However, the precise role of Btn2 in intracellular membrane transport has remained obscure. Here we reveal that role to be the regulation of cargo protein recycling from the late endosome. Thus, we predict that changes in ion, pH, or amino acid homeostasis, seen in the absence of Btn2, result from the improper recycling of cargo proteins within the endomembrane transport system. If so, this would preclude a general role in the regulation of cell homeostasis, as predicted by Kim et al. (43). Furthermore, we predict that Batten disease/JNCL in humans may originate from the failed recycling of cargo proteins to their proper sites of action. This might result in the accumulation of nonrecycled cargo in other intracellular compartments (i.e., lysosome) and lead to cellular dysfunction. Interestingly, a connection between the defects in retromer function and the production of the amyloid-ß peptide, which is involved in the pathogenesis of Alzheimer's disease, has been noted (76). Along with this study, it suggests that alterations in late endosome-Golgi protein recycling may play a significant role in the control of cell metabolism and viability.
Finally, an analysis of a role for Btn1 in endomembrane trafficking would seem to be a high priority, in light of the results obtained with Btn2. BTN1 encodes the yeast ortholog of CLN3 (18, 59), a gene known to be mutated in NCL patients (30, 31, 53). Btn1 has been proposed to play a role in vacuolar pH homeostasis (57) and the import of basic amino acids therein (44), although the mechanism is unknown. Our results may suggest a potential role for Btn1/Cln3 in endosomal protein sorting, which could account for its effects upon vacuolar/lysosomal homeostasis.
This study was supported by grants to J.E.G. from the Batten Disease Research and Support Association (United States), the Josef Cohn Minerva Center for Biomembrane Research, Weizmann Institute (Israel), and the Kekst Family Family Center for Medical Genetics, Weizmann Institute (Israel). J.E.G. holds the Henry Kaplan Chair in cancer research.
Published
ahead of print on 13 November 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»